OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia
Jiali Cheng, Tong Ge, Xiaojian Zhu, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2331-2346
Open Access | Times Cited: 10
Jiali Cheng, Tong Ge, Xiaojian Zhu, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2331-2346
Open Access | Times Cited: 10
Showing 10 citing articles:
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 28
Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 28
CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells
Linqin Wang, Yiyun Wang, Xiangjun He, et al.
Cell Reports Medicine (2025), pp. 101889-101889
Closed Access | Times Cited: 4
Linqin Wang, Yiyun Wang, Xiangjun He, et al.
Cell Reports Medicine (2025), pp. 101889-101889
Closed Access | Times Cited: 4
Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies
Haolong Lin, Xiuxiu Yang, Shanwei Ye, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117252-117252
Open Access | Times Cited: 11
Haolong Lin, Xiuxiu Yang, Shanwei Ye, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117252-117252
Open Access | Times Cited: 11
Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs
Guo Shu-hua, Xiaozhi Xi
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Guo Shu-hua, Xiaozhi Xi
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy
Wanxin Zhao, Yizhou Yao, Qihong Li, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116439-116439
Closed Access | Times Cited: 2
Wanxin Zhao, Yizhou Yao, Qihong Li, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116439-116439
Closed Access | Times Cited: 2
Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy
Minmin Wang, Linzi Jia, Xiangpeng Dai, et al.
Molecular Oncology (2024) Vol. 18, Iss. 8, pp. 1821-1848
Open Access | Times Cited: 1
Minmin Wang, Linzi Jia, Xiangpeng Dai, et al.
Molecular Oncology (2024) Vol. 18, Iss. 8, pp. 1821-1848
Open Access | Times Cited: 1
Immuno-PET Imaging of CD93 Expression with 64Cu-Radiolabeled NOTA-mCD93 ([64Cu]Cu-NOTA-mCD93) and Insulin-Like Growth Factor Binding Protein 7 ([64Cu]Cu-NOTA-IGFBP7)
Xiaoyan Li, Wenyu Song, Jonathan W. Engle, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 1
Xiaoyan Li, Wenyu Song, Jonathan W. Engle, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 1
Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy
Johanna Rausch, Evelyn Ullrich, Michael W.M. Kühn
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Johanna Rausch, Evelyn Ullrich, Michael W.M. Kühn
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Progress in the Utilization of Nanobody CAR-T Cell in Cancer Immunotherapy
Qian Jiang, Wei Shi, Heng Liu, et al.
Journal of Biomedical Nanotechnology (2024) Vol. 20, Iss. 8, pp. 1207-1224
Closed Access
Qian Jiang, Wei Shi, Heng Liu, et al.
Journal of Biomedical Nanotechnology (2024) Vol. 20, Iss. 8, pp. 1207-1224
Closed Access
